1
Additional Abstract from the 35th Annual Meeting of the Society of General Internal Medicine J Gen Intern Med 28(Suppl 1):S490 DOI: 10.1007/s11606-012-2180-8 © Society of General Internal Medicine 2012 TO STAGE OR NOT TO STAGE Nikhil Mukhi; Tushar Shah; Woondong Jeong LEARNING OBJECTIVE 1: The available diagnostic tools may not always give accurate staging of a gastroesophageal tumor. This poses a staging dilemma in GE tumors. CASE: 59 yr old Caucasian Male with no significant medical history presented with 4 month history of worsening dysphagia initially to solids which later progressed to liquids. He denied any nausea, vomiting, diarrhea, melena or blood in stool. He had noticed a 20 pound weight loss in last 3 months. Patient was afebrile with normal blood pressure and heart rate. Patient looked cachetic and didnt have pallor, icterus or palpable lymph- adenopathy. His abdomen was soft, non tender, non distended with normoactive bowel sounds. His stool occult blood was negative. His CT Chest revealed moderate distension of esophagus with irregular wall thickening of GE junction and proximal stomach. CT Abdomen/Pelvis did not demonstrate any other lesions. No intra-abdominal lymphadenopathy or adenexal masses were noted. Patient underwent an endoscopy with EUS which demonstrated a T3 lesion of the gastroesophageal junction. Pathology confirmed a well differentiated adenocarcinoma. Patient underwent a diagnos- tic laparoscopy and J-tube placement. Liver biopsy showed inflammatory mesenchymal cells with normal hepatic parenchyma and peritoneal fluid sampling didnt reveal signs of metastasis. PET scan did not reveal other areas of increased uptake. Based on the information, patient was diagnosed with Stage IIb adenocar- cinoma of GE junction and was treated with neoadjuvant chemotherapy and was awaiting surgical resection. Three days after chemotherapy, patient developed abdominal pain and hypotension, CT Abdomen/Pelvis revealed free air in the abdomen requiring exploratory laparotomy during which an inflamed appendix was visualized. Pathology of resected appendix confirmed metastatic adenocarcinoma. These findings changed his staging to Stage IV adenocarcinoma. DISCUSSION: Adenocarcinoma of upper GI tract has increased 400 percent in the last 25 years in US. They commonly present with intraperitoneal metastasis, often difficult to diagnose. The current NCCN guidelines state all patients with adenocarcinoma of GE junction should get CT of Chest/Abdomen/Pelvis, PET scan and endoscopy with biopsy for staging of the tumor. There is grade B evidence for need of laproscopic evaluation for GE tumors. Our case, despite appropriate imaging, was staged incorrectly. Appropri- ate staging may have saved the patient from surgical trauma and complications but the treatment received would not have been affected. Published online July 26, 2012 S490

Additional Abstract from the 35th Annual Meeting of the Society of General Internal Medicine

  • View
    217

  • Download
    3

Embed Size (px)

Citation preview

Page 1: Additional Abstract from the 35th Annual Meeting of the Society of General Internal Medicine

Additional Abstract from the 35th Annual Meeting of the Societyof General Internal Medicine

J Gen Intern Med 28(Suppl 1):S490

DOI: 10.1007/s11606-012-2180-8

© Society of General Internal Medicine 2012

TO STAGE OR NOT TO STAGENikhil Mukhi; Tushar Shah; Woondong Jeong

LEARNING OBJECTIVE 1: The available diagnostic tools maynot always give accurate staging of a gastroesophageal tumor. Thisposes a staging dilemma in GE tumors.CASE: 59 yr old Caucasian Male with no significant medicalhistory presented with 4 month history of worsening dysphagiainitially to solids which later progressed to liquids. He denied anynausea, vomiting, diarrhea, melena or blood in stool. He hadnoticed a 20 pound weight loss in last 3 months.Patient was afebrile with normal blood pressure and heart rate. Patientlooked cachetic and didn’t have pallor, icterus or palpable lymph-adenopathy. His abdomen was soft, non tender, non distended withnormoactive bowel sounds. His stool occult blood was negative.His CT Chest revealed moderate distension of esophagus withirregular wall thickening of GE junction and proximal stomach.CT Abdomen/Pelvis did not demonstrate any other lesions. Nointra-abdominal lymphadenopathy or adenexal masses were noted.Patient underwent an endoscopy with EUS which demonstrated aT3 lesion of the gastroesophageal junction. Pathology confirmed awell differentiated adenocarcinoma. Patient underwent a diagnos-tic laparoscopy and J-tube placement. Liver biopsy showed

inflammatory mesenchymal cells with normal hepatic parenchymaand peritoneal fluid sampling didn’t reveal signs of metastasis.PET scan did not reveal other areas of increased uptake. Based onthe information, patient was diagnosed with Stage IIb adenocar-cinoma of GE junction and was treated with neoadjuvantchemotherapy and was awaiting surgical resection.Three days after chemotherapy, patient developed abdominal painand hypotension, CT Abdomen/Pelvis revealed free air in theabdomen requiring exploratory laparotomy during which aninflamed appendix was visualized. Pathology of resected appendixconfirmed metastatic adenocarcinoma. These findings changed hisstaging to Stage IV adenocarcinoma.DISCUSSION: Adenocarcinoma of upper GI tract has increased400 percent in the last 25 years in US. They commonly present withintraperitoneal metastasis, often difficult to diagnose. The currentNCCN guidelines state all patients with adenocarcinoma of GEjunction should get CT of Chest/Abdomen/Pelvis, PET scan andendoscopy with biopsy for staging of the tumor. There is grade Bevidence for need of laproscopic evaluation for GE tumors. Ourcase, despite appropriate imaging, was staged incorrectly. Appropri-ate staging may have saved the patient from surgical trauma andcomplications but the treatment received would not have beenaffected.

Published online July 26, 2012

S490